Executives from Bristol-Myers Squibb, Biogen, and GSK attended an event in Princeton, while Quest Diagnostics partnered with Bristol-Myers Squibb.
3 reports, 3 independent
Updated Jun 25
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Executives from Bristol-Myers Squibb, Biogen, and GSK attended an event in Princeton, while Quest Diagnostics partnered with Bristol-Myers Squibb.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Bristol-Myers Squibb
American pharmaceutical company
-
Quest Diagnostics
medical research company
-
GSK
British multinational pharmaceutical and biotechnology company
Related events
- Bristol-Myers Squibb and Johnson & Johnson are both companies that are currently targets of LB Pharmaceuticals.
- Bristol-Myers Squibb has taken ownership of Celgene's drug.
- Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.
- Pfizer is based in New York and Bristol-Myers Squibb is based in Princeton, New Jersey.
- Report covers clinical trials for Mycosis Fungoides involving Bristol-Myers Squibb, Johnson & Johnson, Merck, and Novartis.